content2550

content26351

content24499

content4643

content23458

content16345

content17017

content23755

content555

content1969

content15624

content16705

content8974

content7997

content6963

content8535

content23954

content17321

content15174

content25723

content29253

content24141

content10362

content6989

content11540

content5796

content6088

content9770

content4497

content21860

content18892

content28141

content15958

content6840

content5431

content5188

content22456

content14251

content4330

content23245

content12965

content19114

content28397

content19785

content1277

content9834

content23992

content7705

content8292

content10929

content11339

content8772

content27371

content17497

content16138

content4834

content19380

content5864

content4054

content18449

content10906

content317

content14822

content10380

content23829

content599

content5879

content2123

content3582

content14584

content28375

content27920

content2331

content10006

content10728

content5774

content4978

content2332

content5538

content22890

content5316

content24154

content28176

content14752

content1379

content4194

content28031

content2268

content22768

content3586

content23170

content2425

content1667

content5719

content24958

content23214

content1086

content24450

content5431

content7608

content15566

content27679

content11866

content459

content3463

content1604

content657

content5600

content18763

content15685

content19254

content4785

content26433

content22370

content7350

content12751

content12766

content5426

content22998

content28249

content24766

content5717

content3528

content19866

content448

content232

content12433

content8136

content11790

content28825

content6850

content21430

content10241

content15151

content6618

content18104

content21213

content16602

content9869

content19779

content2014

content5829

content6008

content28983

content7124

content7781

content13703

content7657

content25069

content28934

content17503

content15540

content28762

content696

content11208

content745

content29537

content20019

content10324

content12242

content24598

content24241

content2602

content29920

content1347

content13498

content24477

content25498

content3162

content27337

content27801

content6569

content29469

content12509

content14670

content13077

content15509

content5669

content21214

content27212

content22597

content24870

content19573

content5464

content13242

content24113

content8821

content26904

content8379

content23569

content24716

content6416

content22910

content16801

content18008

content27878

content29906

content18571

content19371

content5465

content4191

content13349

content9508

content22136

content3742

content28996

content20972

content25181

content17291

content18515

content26064

content2537

content2801

content16430

content18887

content23414

content24123

content29834

content7452

content25353

content17107

content7429

content2733

content25930

content3820

content14411

content25580

content7233

content7941

content17073

content10095

content21196

content3726

content27193

content23731

content27083

content6244

content12185

content10088

content17243

content22164

content20915

content16032

content10317

content20197

content4562

content16823

content21104

content17239

content12678

content2774

content4634

content25687

content8665

content9499

content2008

content602

content861

content10019

content6014

content5920

content19830

content8940

content6975

content11129

content15131

content16065

content20173

content9639

content24553

content22157

content24614

content22839

content2864

content5006

content19461

content20791

content25818

content25645

content7512

content14095

content18167

content24362

content28366

content8845

content5297

content19728

content22742

content15197

content7113

content4503

content13288

content23295

content13465

content20772

content26344

content15313

content3744

content11807

content19143

content20303

content7445

content5181

content6349

content13813

content2579

content22108

content3189

content1641

content13106

content15098

content21711

content21110

content7657

content9718

content6137

content2210

content17665

content15243

content10141

content9470

content17734

content18220

content4223

content19206

content23941

content14771

content7009

content4399

content18746

content9193

content26043

content16740

content16464

content1564

content15852

content1908

content11839

content18833

content24532

content12040

content26456

content29490

content12252

content12399

content9649

content10138

content16075

content15124

content22529

content18429

content12293

content21855

content5336

content26957

content15923

content26176

content12485

content11859

content28698

content21746

content197

content20093

content8174

content10902

content29842

content20844

content15817

content26598

content12020

content26614

content22421

content25895

content6525

content6565

content8412

content21716

content26613

content9177

content14533

content5208

content29631

content10095

content28453

content40

content11814

content19696

content19862

content24796

content16357

content23243

content7199

content28423

content17007

content11124

content21678

content18507

content22457

content19343

content168428 content39775 content158236 content70060 content42715 content110685
省重点实验室
当前位置:首页 >研发优势 > 省重点实验室



1.批准建立时间

    浙江省医学生物工程疫苗研究开发重点实验室于2008年由浙江省科学技术厅批准建设,2011年5月通过验收。

2.学科类别
    浙江省卫生行业重点实验室。

3.主要研究方向、内容
   (1) 医学病原生物学、疫苗学和相关免疫学的基础研究;
   (2) 疫苗和生物制剂纯化技术的研究;
   (3) 疫苗病毒库的建立;
   (4) 安全高效新型生物制品的研究与开发;
   (5) 载体系统的研究开发平台;
   (6) 新型免疫佐剂研究;

4.实验室运行管理情况
    浙江省医学生物工程疫苗研究开发重点实验室接受浙江省科学技术厅等有关上级部门组织的领导、监督和检查。
    重点实验室现有科研人员28名,包括中国科学院院士1名,研究员7名,副研究员7名,中级职称10名,其中博士4名,引进海外高层次人才2名。有开展各项研究所需要的仪器,6个P2实验室及疫苗研发所需要的洁净工艺研究室。
    在研项目有国家863项目1项(负责单位),科技部技术支撑子项目1项,浙江省科技厅重大专项3项,国家自然科学基金1项,合作开发研究项目3项;
    重点实验室坚决贯彻“研发、创新、开放、联合”的运行管理方针,充分发挥重点实验室学术委员会的指导、监督工作,合理利用(开放)重点实验室的仪器设备资源,创造良好的科研环境和实验条件。已初步成为有浙江特色,代表我省医学疫苗研究与开发领域学术、技术、科研水平和科技管理水平的研发创新平台。

   
   
银河娱乐_银河娱乐网址_银河娱乐场下载网址
地址:中国浙江省杭州市滨江区滨康路587号 电话:+86-0571-88063547   +86-0571-88861602
国家信息产业部网站备案号:浙ICP备100998656